Funding opportunities available
Orthopaedics Research Society | Young Investigator Initiative
We are pleased to announce that the ORS Young Investigator Initiative (YII) has once again received R13 funding through ORS Member and Principal Investigator, Ed Puzas, PhD, and the University of Rochester. The success of the application, which underwent very rigorous review, is not only a testament to the importance and value of this vital multidisciplinary program, but given the current funding landscape, also serves, in part, to validate the future of musculoskeletal research.
Of particular interest to accepted and prospective applicants is this grant now enables ORS to provide complimentary two-night lodging to all participants.
While the grant aids us financially in delivering this quality program, we would be remiss if we did not acknowledge the generous and immeasurable contributions of our dedicated faculty and mentors who are the heart of YII: Joel Block, MD; Hicham Drissi, PhD; Kharma Foucher, MD, PhD; Howard Hillstrom, PhD; Nancy Lane, PhD; Anne-Marie Malfait, MD, PhD; Ed Puzas, PhD; and Brian Noehren, PhD; as well as ORS leadership, some of whom served as co-investigators on the filing. We appreciate you!
Join us October 17-19, 2025 in Rosemont, IL
The UCSF-Stanford PDC Accelerator, our direct funding program, is offered to participants selected through a Pitch competition in Spring and Fall for accepted applicants. The Accelerator is open to any promising pediatric device idea or project that, if accepted, is willing to invest the necessary time to work with the PDC, our advisors, and our mentors to develop their idea into a marketable product. Projects at any stage of development are encouraged to apply, with no restriction as to the therapeutic area.
Accepted projects considered by the PDC and its advisors to be commercially viable will receive a grant of up to $100,000 along with customized mentoring and commercialization services as appropriate to the project’s stage and needs, including but not limited to: Value estimate coaching, Product development planning, Regulatory strategy, Reimbursement planning, Business planning, Commercialization strategy.
Medline Investigator-Initiated Studies Program | Research support
The IIS Program provides support for research that advances scientific and medical knowledge about Medline products and generates promising approaches to medical care. Our support of projects can include direct funding to cover all or a portion of study-related costs, product and study design input. If the Scientific Review Committee approves an application, execution of an agreement is required for disbursement of funds and/or product, which includes milestones and publishing expectations.
Medline Fellowship Grant | Advancing Education & Training
Fellowships play an important role in ensuring that fellows are trained in the latest medical procedures and technologies.Applications for awards are submitted by teaching institutions, community hospitals, medical societies, and associations that have a bona fide fellowship program and selection process to determine fellowship recipients.
2025 Eli Lilly and Company Grand Challenge Grant Application
The 2025 Grand Challenge will take place at Lilly’s headquarters in Indianapolis, IN on September 3rd and 4th, 2025. Selected participants will be invited to network with Lilly executives and scientists and compete for $100,000 USD in non-dilutive grant funding. Selected participants will also gain access to Lilly’s extensive scientific and business network to help advance their technologies.
The 2025 Grand Challenge will include a track on Genetic Medicine: novel delivery technologies, neuroscience, & regenerative medicine.
Application Deadline: June 27, 2025
Michelson Prizes: Next Generation Grants
Next Generation Grants are $150,000 research grants given annually to support promising researchers applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
While the Michelson Prizes are focused on research in the fields of immunology, vaccine, and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply.
$150,000 / 1-year grants to support research
Researchers 35 years of age and under are eligible
Application Deadline: June 22, 2025
This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that translate technology and therapeutic innovations from academic and other non-profit research sectors to the marketplace to advance the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic, or skin diseases. It supports late-stage pre-clinical research and development, such as moving products towards regulatory approval for clinical testing or making the new lab technologies more practical to use in a clinical setting. It requires close collaboration between the original developers of these technologies and the SBCs.
Application Deadline: 9/5/2024, 1/5/2025, 4/4/2025, 9/5/2025
Sjögren’s Foundation Research Grants
The Sjögren’s Foundation strives to foster innovative research that will have the greatest potential impact on Sjögren’s patients.
The Sjögren’s Foundation Research Grants Program places a high priority on both clinical and basic scientific research into the cause, prevention, detection, treatment, and cure for Sjögren’s with opportunities open to both junior and senior-level investigators at US-based institutions.
Grants Available:
The Sjögren’s Foundation High Impact Grant
The Sjögren’s Foundation Pilot Grant
The Sjögren’s Foundation Dynamic Grant
The Sjögren’s Foundation Partner Grant
Application Deadline: Rolling Basis
Find a full list of RADx-Rad initiatives here >
Archived Opportunities
Grant Title: Applied Research Grant
Application Due Date: February 15-May 15, 2025
ARDF ANNUAL OPEN GRANT PROGRAM
ARDF’s Annual Open grant program was established to fund research projects that develop alternative methods to advance science and replace or reduce animal use. Proposals are welcome from any nonprofit educational or research institution worldwide, although there is a preference for U.S. applications to support advancing alternatives here.
Proposals are evaluated based on scientific merit and feasibility, and the potential to reduce or replace the use of animals in the near future. Proposals are considered across the fields of research, testing, or education. The maximum award amount is $50,000, and the historical funding rate is approximately 20%.
Application Due Date: February 28, 2025
Application Due Date:November 22, 2024, January 31, 2025 by 5:00 PM local time of applicant organization.
Grant Title: The Sjögren’s Foundation Pilot Grant
Application Due Date: Proposals will be accepted through March 1, 2025
Grant Title: NISjögren’s Foundation Research Grants
Application Due Date: Proposals will be accepted through March 1, 2025
Grant Title: Osseointegration Foundation 2025-2026 AO/OF Research Grant
Application Due Date: 01/31/25
Grant Title: Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)
Application Due Date: 11/19/2024
Application Due Date: 09/05/2024
Grant Title: DoD Reconstructive Transplant, Advanced Technology Development Award
Application Due Date: 10/23/2024
Grant Title: 2024 SMILE Health accelerator program
Application Due Date: 5/8/2024
Grant Title: MTF Biologics Innovation in Allografts Translational Grants
Application Due Date: 6/14/2024 (with LOI due on 3/15/2024)
Application Due Date: 9/5/2024
Grant Title: The Pew Biomedical Scholars
Application Due Date: 9/5/2024
Grant Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)(RFA-NS-23-007)
Application Due Date: 9/4/2024, 1/3/2025, 4/4/2025
Grant Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)(RFA-NA-23-006)
Application Due Date: 9/4/2024, 1/3/2025, 4/4/2025
Grant Title: Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)(PAR-23-032)
Application Due Date: 9/5/2024, 1/5/2025, 4/4/2025, 9/5/2025
Grant Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-23-230)
Application Due Date: 9/3/2024
Grant Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) (PA-23-231)
Application Due Date: 9/3/2024
Grant Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) (PA-23-232)
Application Due Date: 9/3/2024
Grant Title: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) (PA-23-220)
Application Due Date: 9/5/2024, 1/5/2025, 4/5/2025
Grant Title: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)(PA-23-219)
Application Due Date: 9/5/2024, 1/5/2025, 4/5/2025
Grant Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) (PA-23-233)
Application Due Date: 9/3/2024
Application Due Date:6/18/2024, 10/17/2024 (with LOIs due 30 days prior to the application due date)
For the full list of RADx-Rad initiatives please visit – https://www.nih.gov/research-training/medical-research-initiatives/radx/funding
To view background information regarding the Regenerative Medicine Innovation Project see NIH website here.
Grant Title: Defense Health Program Department of Defense Reconstructive Transplant Research Program Anticipated Funding Opportunities for Fiscal Year 2023 (FY23) (A pre-application is required)
Application Due Date: To be released soon